REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPM.L Regulatory News (MPM)

  • There is currently no data for MPM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New commercial agreement for IMPACT

7 Mar 2017 07:00

RNS Number : 6565Y
mporium Group PLC
07 March 2017
 

7 March 2017

mporium Group plc

("mporium" or the "Group")

New commercial agreement for IMPACT

mporium Group plc (AIM:MPM), the "mobile native" technology firm, is pleased to announce a commercial agreement to provide its IMPACT technology product to Essence, a market-leading global digital agency that is majority owned by WPP. This new agreement follows the successful trial of IMPACT on the digital marketing campaign for two of Essence's largest blue-chip clients.

mporium's commercial arrangement with Essence represents a very significant step forward in the commercialisation of IMPACT. The agreement provides the opportunity to work with Essence's global client base.

mporium, is a "mobile native" technology company that enables brands, and the agencies that serve them, to achieve better outcomes from digital advertising campaigns. Uniquely, mporium uses proprietary technology to achieve successful digital advertising campaigns on mobile devices, from brand advertising to direct response.

IMPACT leverages a range of data inputs, including TV, news, sports and social media to manage in real-time the pricing, timing and selection of creative for digital advertising campaigns.

During the trials, mporium used its proprietary technology to perform content switching on both Google AdWords and Facebook. The triggers for these switches were brand-relevant content on TV, live sports and RSS feeds.

The performance generated by the trials was recognised by Essence signing a commercial agreement for the use of mporium's technology.

 

Regarding the agreement, Ryan Storrar, Head of Biddable Platforms, Essence said:

"Essence is renowned for blending data science, objective media and captivating experiences to build valuable connections between brands and consumers. After completing successful trials with two of our clients, we have seen the benefits that mporium IMPACT can deliver. Essence are pleased to have signed a commercial agreement with mporium, that will allow our clients to leverage mporium's IMPACT Technology on demand."

On securing the agreement mporium's CEO Barry Moat said:

"Essence are widely regarded as one of the most innovative digital agencies. It is a great endorsement for mporium to announce this commercial agreement with an agency of Essence's calibre and it marks a very significant milestone in our company's development."

Enquiries

 

mporium:

020 3242 0515

Barry Moat

 

 

 

N+1 Singer:

020 7496 3000

Gillian Martin

Alex Laughton-Scott

 

 

 

Buchanan:

020 7466 5000

Charles Ryland

 

Victoria Hayns

 

 

Notes to editors

About mporium

mporium, is a "mobile native" technology company that enables brands, and the agencies that serve them, to achieve better outcomes from digital advertising campaigns. Uniquely, mporium uses proprietary technology to achieve successful digital advertising campaigns on mobile devices, from brand advertising to direct response. Based in the UK, mporium Group plc is quoted on AIM, the junior market of the London Stock Exchange plc.

About Essence

Essence is a global digital agency that blends data science, objective media and captivating experiences to build valuable connections between brands and consumers. Clients include Google, Tesco Mobile and the Financial Times. The agency is more than 540 people strong, manages over $850MM in media spend and deploys campaigns in 71 markets via offices in Chicago, Delhi, London, New York, San Francisco, Seattle, Shanghai, Singapore, Sydney and Tokyo. Part of GroupM, Essence is majority owned by WPP, the world's leading communications services group.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGROKADQPBKDCNK
Date   Source Headline
6th Jun 20147:00 amRNSAGM Statement
23rd May 20147:00 amRNSContract wins
22nd May 20145:00 pmRNSCompletion of audit
21st May 20145:06 pmRNSAnnual General Meeting
13th May 20147:00 amRNSResults for year ended 31 December 2013
29th Apr 201411:30 amRNSNotice of results & new product launch
31st Mar 20147:00 amRNSTOTAL VOTING RIGHTS
21st Mar 20147:00 amRNSAgreement with Affiliate Window
12th Mar 20143:39 pmRNSDirector/PDMR Shareholding
11th Mar 20144:35 pmRNSBlock Admission Application
7th Mar 20147:00 amRNSNew Customer and Sector Wins
20th Jan 20147:00 amRNSPRE-CLOSE TRADING UPDATE
17th Jan 201410:17 amRNSHoldings in Company
18th Dec 20137:00 amRNSFirst Day of Dealings
5th Mar 20107:00 amRNSOffer Update
5th Mar 20107:00 amRNSCompulsory Acquisition of Minster Shares
17th Feb 20107:14 amRNSBoard Changes, Issue of Deferred Consideration
17th Feb 20107:00 amRNSOffer Update
1st Feb 201012:50 pmRNSDirectorate Change
25th Jan 20105:51 pmRNSEPT Disclosure
20th Jan 201011:59 amRNSRule 8.3- Minster Pharmaceuticals PLC
14th Jan 20104:00 pmRNSPosting of Offer Document
14th Jan 20104:00 pmRNSPosting of Offer Document
13th Jan 20102:27 pmRNSRule 8.3- Minster Pharma PLC
4th Jan 20103:11 pmRNSAcquisition of Minster Pharmaceuticals
4th Jan 20103:11 pmRNSCash Offer
20th Nov 20097:00 amRNSInterim Results
21st Sep 20097:00 amRNSDirectorate Change
15th Sep 20093:31 pmRNSChange of Registered Office
14th Sep 20097:00 amRNSTonabersat at IHS Congress
23rd Jul 20097:00 amRNSSabcomeline Patent Filing
17th Jul 200910:39 amRNSDirector/PDMR Shareholding
6th Jul 20097:00 amRNSPublication of Aura Results
30th Jun 200911:30 amRNSResult of AGM
30th Jun 20097:01 amRNSAGM Statement
30th Jun 20097:00 amRNSRajinder Kumar Appointment
2nd Jun 20095:04 pmRNSAnnual Financial Report
29th May 200910:51 amRNSGrant of Share Option to Director
29th May 200910:47 amRNSDirector/PDMR Shareholding
28th May 20097:00 amRNSPreliminary Results
20th Apr 20097:00 amRNSKarl Keegan appointed CFO
17th Apr 20097:16 amRNSDirectorate Change
11th Feb 20093:39 pmRNSHolding(s) in Company
2nd Feb 20097:00 amRNSTempus Study Results
18th Dec 200811:52 amRNSHolding(s) in Company
4th Dec 20087:00 amRNSUS Licensing Consultant
14th Nov 20087:00 amRNSInterim Results
11th Nov 20087:00 amRNSNotice of Interim Results
22nd Oct 20087:00 amRNSPositive Phase II Results
30th Jun 20087:00 amRNSSymposium at AHS Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.